Recent advances in anticoagulant-related nephropathy: risk factors, peribiopsy and therapeutic anticoagulation

Clicks: 28
ID: 328353
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #42 of 228 articles by views in clinical kidney journal

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 228 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract The concept of anticoagulant-related nephropathy (ARN), first proposed in 2009, manifests as acute kidney injury or the rapid deterioration of chronic kidney disease secondary to anticoagulant therapy. Large numbers of tubular RBCs and/or tubular RBC casts and ATN, without active glomerulonephritis are the main pathological features. The history of anticoagulant drug use and pathological manifestations are the most important characteristics that distinguish it from other renal injuries. ARN is considered rare, with just over 100 cases documented globally, yet its incidence may be underestimated due to limited awareness. This article reviews the epidemiology, risk factors, etiology and pathogenesis, diagnosis and treatment of ARN. New advances in recent years are highlighted, including the relationship between ARN and other kidney diseases, the characteristics of non-vitamin K oral anticoagulants and their effects on renal function, and the complexities of peri-biopsy and therapeutic anticoagulation. To address the critical peri-biopsy management impasse, we evaluated anticoagulation strategies from published case reports. Integrating these empirical insights with established perioperative antithrombotic principles, we propose a synthesized strategy for ARN management during the peri-biopsy and treatment phases, accompanied by a diagnostic flowchart. Given the current reliance on case-level evidence, this review does not intend to issue definitive clinical guidelines. Rather, it aims to build a comprehensive cognitive framework and a structured consideration system, facilitating nuanced assessments to ultimately improve patient outcomes in this challenging clinical domain.
Reference Key
openalex_W7212355972 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Yiwen Chen, Hao Yan, JingJing Wu, Huixia Liu, Yujuan Li, Ye Yao, Chun Zhang, Jing Xiong
Are you one of these authors? Claim your profile
Journal clinical kidney journal
Year 2026
DOI
10.1093/ckj/sfag325
URL
https://academic.oup.com/ckj/advance-article-pdf/doi/10.1093/ckj/sfag325/71048086/sfag325.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.